New painkiller GRT7041 enters first human safety trial
NCT ID NCT07289776
First seen Jan 10, 2026 · Last updated May 17, 2026 · Updated 19 times
Summary
This early-stage trial tests a new drug called GRT7041 for pain. It involves 70 healthy volunteers to check safety, side effects, and how the body processes the drug. The study is split into single and multiple dose parts, lasting up to 8 weeks. It is not yet testing the drug on people with pain.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TREATMENT OF PAIN are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
New Zealand Clinical Research (NZCR)
RECRUITINGChristchurch, 8011, New Zealand
Contact Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.